Dr. Jill Biden and the White House this week announced that $100 million in federal funding will go toward research and development into women’s health. The First Lady said the funding is part of a White House Initiative on Women’s Health Research that the White House announced in November. The Federal Department of Health and […]
Women's Health
FDA clears surgical guidance system from Merit Medical
Merit Medical Systems (Nasdaq:MMSI) announced today that it received FDA 510(k) clearance for the Scout MD surgical guidance system. Scout MD broadens the South Jordan, Utah–based company’s oncology portfolio. Merit designed the system to enhance the diagnosis and treatment of breast cancer, as well as other soft tissue cancers. The system includes the Scout radar […]
UroMems has positive results for first-ever female implant of smart urinary sphincter system
UroMems announced today that it successfully met the six-month primary endpoint for the first female patient implanted with UroActive. Grenoble, France-based UroMems designed its smart UroActive implant to treat stress urinary incontinence (SUI). The company says it’s the first smart, automated artificial urinary sphincter (AUS) to treat SUI. Powered by a MyoElectroMechanical system (MEMS), UroActive […]
FDA clears new cervical cytology AI tech from Hologic
Hologic announced that the FDA granted clearance for its Genius digital diagnostics system with the Genius cervical AI algorithm. Clearance makes Genius the first and only FDA-cleared digital cytology system combining deep learning-based AI with advanced volumetric imaging technology to help identify pre-cancerous lesions and cervical cancer cells, according to a news release. Hologic’s clearance […]
Biorithm raises $3.5M Series A for remote maternal monitoring tech
Biorithm announced that it closed a $3.5 million Series A funding round to support its personalized, connected maternity care technology. Adaptive Capital Partners and SEEDS Capital co-led the funding round. Cambridge, Massachusetts-based Biorithm plans to use the funds to fuel its expansion in Southeast Asia and the U.S. It also plans to use the cash […]
SimBioSys wins FDA nod for TumorSight precision medicine platform
SimBioSys announced that it received FDA 510(k) clearance for its TumorSight cloud-based digital precision medicine platform. FDA clearance came just days after the company inked a partnership with Mayo Clinic to develop precision medicine solutions. The TumorSight platform takes a patient’s standard-of-care imaging to build a custom 3D model of their tumor. The tool provides […]
SimBioSys, Mayo Clinic partner on AI-powered tech for breast cancer patients
SimBioSys announced today that it entered into a strategic collaboration with Mayo Clinic to develop digital precision medicine solutions. The collaboration aims to develop cloud-based clinical software to support end-to-end decision-making for early-stage breast cancer patients. This includes individualized surgical planning, treatment, drug selection and risk stratification. As part of the collaboration, SimBioSys has had […]
Hologic promotes from within to fill COO spot
Hologic announced that it promoted Essex Mitchell to the role of chief operating officer, effective Jan. 1, 2024. Mitchell, 44, originally joined Hologic in September 2017 as VP of sales and commercial excellence for the GYN surgical decision. He currently serves as president of GYN surgical solutions, a post he assumed in August 2020. Mitchell […]
Caldera Medical appoints new CFO
Caldera Medical this week announced it appointed John Pitstick as chief financial officer and executive VP of corporate development. The company said the appointment will allow it to focus on advancing Caldera’s position in the women’s health sector with M&A activity during rapid expansion. Pitstick began his career at Ernst & Young managing a global […]
GE HealthCare unveils AI-powered breast cancer detection suite
GE HealthCare announced today that it launched a new, all-in-one AI platform to support breast cancer detection. The initial release of the GE HealthCare MyBreastAI Suite integrates three AI applications from iCad. That includes the ProFound AI for DBT, part of a platform that iCad today said demonstrates accurate breast cancer risk detection. It also […]
iCad AI tech accurately predicts breast cancer risk, provides heart disease insights
iCad (Nasdaq:ICAD) today announced plans to present new studies validating its AI-powered ProFound Breast Health Suite. ProFound helps to uncover hidden heart or vascular disease and predict a woman’s risk for developing breast cancer in the next 1-2 years. The platform can screen a single mammogram for two of the top causes of death for […]